IFITM1 is a Novel, Highly Sensitive Marker for Endometriotic Stromal Cells in Ovarian and Extragenital Endometriosis
Abstract
When the presence of endometriotic lesions are not evident by hematoxylin and eosin staining, CD10 is used to highlight and confirm the presence of endometriotic stroma. However, CD10 is not specific only to the endometrial stroma but is also expressed in many other cells. Recently, interferon-inducible transmembrane protein 1 (IFITM1) was reported as a highly specific immunohistochemical marker of normal endometrial stroma and endometrial stromal neoplasm. In this study, we examined the expression of IFITM1 and CD10 in 18 cases of ovarian endometriosis and 44 cases of extragenital endometriosis. Among the 62 patients, 62 (100.0%) were positive for IFITM1 and 60 (96.8%) for CD10, and CD10 was negative in 2 cases that were positive for IFITM1. Additionally, we found that IFITM1 sensitivity was unaffected by the presence or absence of hormonal therapy. To the best of our knowledge, this represents the first demonstration of IFITM1 as a highly sensitive stromal marker of ovarian and extragenital endometriosis.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The authors' group also reported IFITM1 as a novel stromal marker for ovarian and extragenital endometriosis including TE.
“Our group also reported IFITM1 as a novel stromal marker for ovarian and extragenital endometriosis including TE.”
From Extra-pelvic endometriosis: a review. (2020) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Zondervan, K. T., Becker, C. M., Koga, K., Missmer, S. A., Taylor, R. N., & Viganò, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0008-5 · Cited by 1,257 · see citing works
Self-citationFriedman, R. L., Manly, S. P., McMahon, M., Kerr, I. M., & Stark, G. R. (1984) · Cell · doi:10.1016/0092-8674(84)90270-8 · Cited by 718 · see citing works
IFITM-Family Proteins: The Cell's First Line of Antiviral Defense
Bailey, C. C., Zhong, G., Huang, I., & Farzan, M. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085537 · Cited by 470 · see citing works
Paraffin-Section Detection of CD10 in 505 Nonhematopoietic Neoplasms
Chu, P. G., & Arber, D. A. (2000) · American Journal of Clinical Pathology · doi:10.1309/8vav-j2fu-8cu9-ek18 · Cited by 370 · see citing works
McCluggage, W. G., Sumathi, V. P., & Maxwell, P. (2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01215.x · Cited by 355 · see citing works
A single DNA response element can confer inducibility by both alpha- and gamma-interferons.
Reid, L. E., Brasnett, A. H., Gilbert, C. S., Porter, A. C. G., Gewert, D. R., Stark, G. R., & Kerr, I. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.840 · Cited by 257 · see citing works
Time to redefine endometriosis including its pro-fibrotic nature
Vigano, P., Candiani, M., Monno, A., Giacomini, E., Vercellini, P., & Somigliana, E. (2018) · Human Reproduction · doi:10.1093/humrep/dex354 · Cited by 235 · see citing works
Sumathi, V. P., & McCluggage, W. G. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.5.391 · Cited by 197 · see citing works
CD10 is a Marker for Normal and Neoplastic Endometrial Stromal Cells
Toki, T., 清水, 元., Takagi, Y., et al. (2002) · International Journal of Gynecological Pathology · doi:10.1097/00004347-200201000-00008 · Cited by 155 · see citing works
D′Angelo, E., Spagnoli, L. G., & Prat, J. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.03.018 · Cited by 104 · see citing works
Hatano, H., Kudo, Y., Ogawa, I., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4761 · Cited by 96 · see citing works
IFITM1 promotes the metastasis of human colorectal cancer via CAV-1
Yu, F., Xie, D., Ng, S. S., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.034 · Cited by 86 · see citing works
Yu, F., Ng, S. S., Chow, B., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0377-4 · Cited by 79 · see citing works
Mikami, Y., Sakae, H. A. T. A., Kiyokawa, T., et al. (2002) · Modern Pathology · doi:10.1097/01.mp.0000026058.33869.db · Cited by 78 · see citing works
Diagnostic Immunohistochemistry in Uterine Sarcomas
Abeler, V. M., & Nenodovic, M. (2011) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e318200caff · Cited by 73 · see citing works
CD10 immunohistochemical staining enhances the histological detection of endometriosis
Potlog‐Nahari, C., Feldman, A. L., Stratton, P., Koziol, D. E., Segars, J. H., Merino, M. J., & Nieman, L. K. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.11.059 · Cited by 69 · see citing works
Groisman, G. M., & Meir, A. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-1003-cihido · Cited by 59 · see citing works
CD10 Expression in the Female Genital Tract
Oliva, E. (2004) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000138140.81139.46 · Cited by 46 · see citing works
Busca, A., Gulavita, P., Parra‐Herran, C., et al. (2017) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000424 · Cited by 44 · see citing works
Fukuda, S., Hirata, T., Neriishi, K., Nakazawa, A., Takamura, M., Izumi, G., Harada, M., Hirota, Y., Koga, K., Wada-Hiraike, O., et al. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.04.021 · Cited by 44 · see citing works
Self-citationParra‐Herran, C., Yuan, L., Nucci, M. R., et al. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.123 · Cited by 35 · see citing works
Individualized management of umbilical endometriosis: A report of seven cases
Saito, A., Koga, K., Osuga, Y., Harada, M., Takemura, Y., Yoshimura, K., Yano, T., & Kōzuma, S. (2013) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12118 · Cited by 25 · see citing works
Self-citationBusca, A., Djordjevic, B., Giassi, A. C. C., et al. (2016) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqw021 · Cited by 15 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Extra-pelvic endometriosis: a review.
Hirata, T., Koga, K., & Osuga, Y. (2020) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12340 · Cited by 107 · see citing works
Self-citation
- Authors
- Sun, H., Fukuda, S., Hirata, T., Arakawa, T., Ma, S., Neriishi, K., Wang, Y., Takeuchi, A., Saeki, A., Harada, M., Hirota, Y., Matsumoto, T., Koga, K., Wada-Hiraike, O., Kurihara, M., Fujii, T., & Osuga, Y.
- Affiliations
- The University of Tokyo (JP)
- Osaka Hospital (JP)
- Nissan Tamagawa Hospital (JP)
- Corresponding author
- Hirata, Tetsuya
- ORCID
- Venue
- Reproductive Sciences
- Published
- 2020-05-20
- Volume
- 27
- Issue
- 8
- Pages
- 1595-1601
- ISSN
- 1933-7191 (ISSN-L)
- 1933-7205
- OpenAlex
- W4245371845
- Cited by
- 19
- References
- 23
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 3
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Reproductive Sciences (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (18K09248, 19H03144, 18K09221)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- IFITM1, CD10, endometrioma, extragenital endometriosis, immunohistochemical markers, endometriosis diagnosis, hormone therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
